Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

The rise in pancreatic cancer diagnoses can be attributed to detection of smaller, early-stage endocrine cancer, and not an increase in pancreatic adenocarcinoma, according to a study published Nov.

In the study, 34 patients with stage 4 metastatic pancreatic cancer were randomized ... the UI team also included cancer ...

What we did here is look at tissue in 3D and then map the genetic alterations onto that 3D model,” explained Laura Wood, M.D., Ph.D., Associate Professor of Pathology and Oncology at the Johns Hopkins ...

Researchers at the University of Massachusetts Amherst and UMass Chan Medical School have demonstrated in mice a new method ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

OCALA, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today announced that data were published on Roswell Park Comprehensive Cancer Center’s Phase 1 study ...

(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins ...